Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,613 | N/A | N/A | -1,080 | -1,890 |
| Depreciation Amortization | 161 | N/A | N/A | 130 | 110 |
| Accounts receivable | -191 | N/A | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | 106 | N/A | N/A | 0 | 0 |
| Other Working Capital | -82 | N/A | N/A | 890 | 1,040 |
| Other Operating Activity | -12 | 0 | 0 | 70 | 70 |
| Operating Cash Flow | $-2,631 | $N/A | $N/A | $10 | $-670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | N/A | 0 | -10 |
| Other Investing Activity | -2 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-11 | $N/A | $N/A | $0 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,650 | N/A | N/A | 0 | 0 |
| Other Financing Activity | 0 | 0 | 0 | -490 | 390 |
| Financing Cash Flow | $8,650 | $N/A | $N/A | $-490 | $390 |
| Exchange Rate Effect | 106 | N/A | N/A | 0 | 0 |
| Beginning Cash Position | 2,464 | N/A | N/A | 1,160 | 1,450 |
| End Cash Position | 8,578 | N/A | N/A | 680 | 1,160 |
| Net Cash Flow | $6,114 | $N/A | $N/A | $-480 | $-280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,631 | N/A | N/A | 10 | -670 |
| Capital Expenditure | -9 | N/A | N/A | 0 | 0 |
| Free Cash Flow | -2,640 | 0 | 0 | 10 | -670 |